Abicipar for Neovascular Age‐Related Macular Degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
Ophthalmology 2020 Nov 19;[EPub Ahead of Print], RN Khurana, D Kunimoto, YH Yoon, CC Wykoff, A Chang, RK Maturi, H Agostini, E Souied, DR Chow, AJ Lotery, M Ohji, F Bandello, R Belfort, XY Li, J Jiao, G Le, K Kim, W Schmidt, Y HashadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.